Technical Analysis on Hologic Inc. and St. Jude Medical Inc. - Medical Appliance & Equipment Makers Evolving

Marketwired

NEW YORK, NY--(Marketwire - Oct 31, 2012) - With healthcare reform threatening to eat into sales for several companies, many in the medical appliances & equipment industry have been working hard to bring new products to market. Companies like Hologic Inc. and St. Jude Medical Inc. are working on a number of products, and those that can get FDA approval could outperform their peers in these difficult times. StBulls.com has initiated technical analysis on Hologic Inc. (NASDAQ: HOLX) and St. Jude Medical Inc. (NYSE: STJ) which serves the Medical Appliances & Equipment industry. These reports are free upon registration. Rest assured that there is no financial commitment to sign up on 

http://www.stbulls.com/registration.php

www.StBulls.com enthuses to bring the best from the internet under one roof, providing you with a one click opportunity to view what the market and financial researchers globally have to say about any particular bellwether stocks in any given financial environment. We work with a number of financial professionals and a dedicated team of researchers that use their acute knowledge to help you manage your understanding of the market. To be part of this community please sign up at

http://www.stbulls.com/registration.php 

Hologic has had some recent success in regards to FDA approval, as the company announced that the FDA had approved its APTIMA HPV 16 18/45 Genotype Assay for use on its TIGRIS instrument system. The approval is the first for a test of genotyping human papillomavirus (HPV) types 16, 18 and/or 45, which are associated with about 80% of all invasive cervical cancers globally. Read our technical analysis on Hologic Inc. by clicking on

http://www.stbulls.com/HologicInc31102012.pdf  

Earnings results in the industry have been mixed in the 3rd quarter, as fierce competition and a soft macroeconomic climate have weighed on results in some cases. St. Jude Medical had a challenging quarter, as its net sales contracted by 4% when compared to the same period last year. Investors looking for technical analysis on St. Jude Medical Inc. are encouraged to use the link below

http://www.stbulls.com/StJudeMedicalInc31102012.pdf

About Street Bulls
STREET BULLS is committed to provide the investor community with sharp and timely trading and investing advice. Our aim is to help our readers achieve above-average returns from the markets and create wealth for themselves. Whether you are a first time investor, a seasoned pro, an "in and out" day trader or a long-term investor, our newsletters and trading advice will provide you with the information you need for success in today's volatile markets.

To view our disclaimer, use this link
http://www.stbulls.com/disclaimer.html.

Contact:
Contact Person:

Martin Peters
Marketing Consultant
info@stbulls.com

View Comments (0)